Chemical-structure (Chemical Structure)
Chemical structure of alendronate sodium trihydrate showing its molecular bonds and functional groups.*
Alendronate Sodium
Product Images NDC 50090-1802
9 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 50090-1802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Figure 1)
A line graph showing the cumulative incidence of hip fractures over 36 months in a three-year study of patients with radiographic vertebral fractures at baseline. The graph compares two groups: placebo and Alendronate Sodium, with cumulative incidence on the y-axis (%) and time in months on the x-axis.*
Figure2 (Figure2)
Bar chart titled 'Osteoporosis Treatment Studies in Postmenopausal Women' showing percentage increase in bone mineral density (BMD) at three years with Alendronate 10 mg/day. The chart compares results between U.S. and Multinational studies across three bone sites: Lumbar Spine, Femoral Neck, and Trochanter, with BMD increase percentages on the vertical axis.*
Figure3 (Figure3)
Figure depicting osteoporosis treatment studies in postmenopausal women, showing the time course of the effect of Alendronate Sodium 10 mg/day versus placebo on lumbar spine bone mineral density (BMD) percent change from baseline over 36 months. The chart includes separate line graphs for a U.S. study and a multinational study, comparing mean percent BMD change with error bars.*
Figure4 (Figure4)
Figure showing bar graphs comparing the mean percentage change in bone mineral density (BMD) from baseline in postmenopausal women receiving Alendronate 5 mg/day versus placebo. Two charts present BMD changes over 2-year and 3-year osteoporosis prevention studies at four anatomical sites: lumbar spine, femoral neck, trochanter, and total body.*
Figure5 (Figure5)
A bar chart titled 'Studies in Glucocorticoid-Treated Patients Increase in BMD Alendronate 5 mg/day at One Year' showing mean percentage increase in bone mineral density (BMD) relative to placebo with standard error bars. It compares U.S. and multinational data for lumbar spine, femoral neck, and trochanter regions.*
Figure6 (Figure6)
Line graph comparing the effect of Alendronate 40 mg/day, Etidronate 400 mg/day, and placebo on serum alkaline phosphatase levels over 6 months in Paget's Disease of Bone studies. The vertical axis shows mean percentage change from baseline, with Alendronate groups demonstrating a larger decrease than Etidronate or placebo.*
Label Image (Lbl500901802)
Alendronate Sodium 70 mg tablet carton label from A-S Medication Solutions. The label indicates the product number, strength of 70 mg per tablet, package quantity of 4 tablets, and storage instructions to keep at 68-77 degrees F. The label also notes the drug is prescription only and distributed by ASM in Libertyville, IL.*
Label Image (Lbl500901803)
Label for Alendronate Sodium 35 mg tablets by A-S Medication Solutions. The label displays the product number 6047-0, states each tablet contains 35 mg of alendronate sodium, with 45.6 mg alendronate sodium corresponding to 35 mg free acid equivalent. The package contains 4 tablets and storage instructions specify 60-77 degrees F. Distribution is by A-S Medication Solutions, Libertyville, IL 60048.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
